GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers
Top Cited Papers
- 1 June 2007
- Vol. 54 (5), 713-720
- https://doi.org/10.1016/j.neuron.2007.05.022
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brainPhysiological Genomics, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Genome-wide atlas of gene expression in the adult mouse brainNature, 2006
- A haplotype map of the human genomeNature, 2005
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and MemoryJournal of Neuroscience, 2005
- The absence of Grb2-associated binder 2 (Gab2) does not disrupt NK cell development and functionsJournal of Leukocyte Biology, 2004
- PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutationsThe EMBO Journal, 2004
- A 4-Mb High-Density Single Nucleotide Polymorphism-Based Map around Human APOEGenomics, 1998
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991